Gabapentin Capsule
Product Images NDC 70010-928

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70010-928). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70010-926-01-jpg-jpg.jpg (70010 926 01 Jpg Jpg)

Label for Gabapentin Capsules, USP 100 mg, an oral human prescription drug by Granules Pharmaceuticals Inc. The label states a package count of 100 capsules and includes storage instructions, dosage reference to package insert, pharmacist dispensing information, manufacturer details (Granules India Limited, Hyderabad, India), and barcodes. The label also mentions the Medication Guide availability online.*

FDA Label Image

70010-926-10-jpg.jpg (70010 926 10 Jpg)

Gabapentin Capsules, USP 100 mg oral capsules label for a package containing 1000 capsules. The label includes drug storage instructions, dispensing guidance, manufacturer details Granules India Limited, and Granules Pharmaceuticals Inc. as the labeler. Barcodes and NDC number 70010-926-10 are also visible.*

FDA Label Image

70010-927-01-jpg.jpg (70010 927 01 Jpg)

Label for Gabapentin Capsules, USP 300 mg, oral capsules in a package of 100 capsules. The label includes storage instructions, dosage advice to see the package insert, and directs dispensing with a medication guide. Manufactured by Granules India Limited in India and labeled for Granules Pharmaceuticals Inc., Chantilly, VA. Barcode and NDC 70010-927-01 are shown.*

FDA Label Image

70010-927-10-jpg.jpg (70010 927 10 Jpg)

Gabapentin Capsules, USP 300 mg oral capsules label from Granules Pharmaceuticals Inc. The label states 1000 capsules per package, each containing 300 mg gabapentin. Storage instructions specify 20°C (68°F to 77°F) with permitted excursions. It includes dispensing and manufacturer information, barcodes, and the note to dispense medication guides separately.*

FDA Label Image

70010-928-01-jpg.jpg (70010 928 01 Jpg)

Label for Gabapentin Capsules, USP 400 mg by Granules Pharmaceuticals Inc. The label indicates the product contains 100 capsules. It includes storage instructions, dosage directions referring to a package insert, manufacturer details for Granules India Limited in India, and that the product is Rx only. The label features two barcodes and a pharmacist instruction to dispense the Medication Guide.*

FDA Label Image

Gaba-fig-1-jpg.jpg (Gaba Fig 1 Jpg)

A line graph showing mean pain score over 8 weeks for Gabapentin 3600 mg/day versus placebo. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis measures mean pain score from 0 to 10. Gabapentin's pain scores decrease steadily compared to placebo, which remains relatively flat.*

FDA Label Image

Gaba-fig-2-jpg.jpg (Gaba Fig 2 Jpg)

A line graph depicting the mean pain score over a 7-week period, divided into a 3-week dose titration and a 4-week fixed dose phase. It compares placebo with Gabapentin at dosages of 1800 mg/day and 2400 mg/day. The y-axis represents mean pain score ranging 0 to 10, and the x-axis represents weeks from baseline to 7.*

FDA Label Image

Gaba-fig-3-jpg.jpg (Gaba Fig 3 Jpg)

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) groups with Gabapentin (GBP) treatment groups. Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo and 32% and 34% for GBP 1800 mg and 2400 mg respectively. Statistical significance is indicated by asterisks: ** p < 0.01 and *** p < 0.001.*

FDA Label Image

Gaba-fig-4-jpg.jpg (Gaba Fig 4 Jpg)

A scatter plot comparing differences (%) against daily dose (mg) for three studies labeled a, b, and c. Study a uses black squares, study b gray squares, and study c white squares. Daily doses range from 600 to 1800 mg, with difference percentages on the vertical axis from 2% to 22%. The data points show variation among the three studies at doses around 600, 900, 1200, and 1800 mg.*

FDA Label Image

Gaba-structure.jpg (Gaba Structure)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxymethyl group (CH2CO2H).*

FDA Label Image

Gabapentin-formula-jpg.jpg (Gabapentin Formula Jpg)

A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a factor adjustment for female patients is shown. The formula is likely part of pharmacokinetic or dosing information related to Gabapentin capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.